Design and evaluation of (32)P-labeled hydroxyapatite nanoparticles for bone tumor therapy

The clinical diagnosis and treatment of malignant bone tumors are still major clinical challenges due to their high incidence are difficulty. Targeted therapies have become a critical approach to treat bone tumors. In recent years, radiopharmaceuticals have been used widely and have shown potent and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Dongliang, Wang, Yumei, Yu, Songke, Zhou, Jiren, Song, Jia, Hao, Shilei, Chen, Xiaoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873276/
https://www.ncbi.nlm.nih.gov/pubmed/36688268
http://dx.doi.org/10.1080/10717544.2023.2168791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873276/
https://www.ncbi.nlm.nih.gov/pubmed/36688268
http://dx.doi.org/10.1080/10717544.2023.2168791

Ejemplares similares